Related Experiment Video
Updated: May 23, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by
Sven Malm1, Monika Jusko, Sigrun Eick
1Section of Medical Protein Chemistry, Department of Laboratory Medicine, Skåne University Hospital, Lund University, Malmö, Sweden.
Abstract:
Infection with the Gram-negative pathogen Prevotella intermedia gives rise to periodontitis and a growing number of studies implies an association of P. intermedia with rheumatoid arthritis. The serine protease Factor I (FI) is the central inhibitor of complement degrading complement components C3b and C4b in the presence of cofactors such as C4b-binding protein (C4BP) and Factor H (FH). Yet, the significance of complement inhibitor acquisition in P. intermedia infection and FI binding by Gram-negative pathogens has not been addressed. Here we show that P. intermedia isolates bound purified FI as well as FI directly from heat-inactivated human serum. FI bound to bacteria retained its serine protease activity as shown in degradation experiments with (125)I-labeled C4b. Since FI requires cofactors for its activity we also investigated the binding of purified cofactors C4BP and FH and found acquisition of both proteins, which retained their activity in FI mediated degradation of C3b and C4b. We propose that FI binding by P. intermedia represents a new mechanism contributing to complement evasion by a Gram-negative bacterial pathogen associated with chronic diseases.
Insights
Prevotella intermedia, a pathogen linked to periodontitis and rheumatoid arthritis, acquires the complement inhibitor Factor I (FI). This binding helps the bacteria evade the host immune system, representing a novel evasion mechanism.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Prevotella intermedia is a Gram-negative pathogen associated with periodontitis and rheumatoid arthritis.
- The serine protease Factor I (FI) is crucial for inhibiting complement system components C3b and C4b, requiring cofactors like C4b-binding protein (C4BP) and Factor H (FH).
Purpose of the Study:
- To investigate whether Prevotella intermedia acquires complement inhibitor Factor I (FI).
- To determine if acquired FI retains its enzymatic activity and if associated cofactors are also acquired.
- To explore a potential novel complement evasion mechanism by P. intermedia.
Main Methods:
- Incubation of Prevotella intermedia isolates with purified FI and FI from heat-inactivated human serum.
- Assessing the serine protease activity of bound FI using (125)I-labeled C4b.
- Investigating the binding and functional activity of cofactors C4BP and FH in the presence of acquired FI.
Main Results:
- Prevotella intermedia isolates successfully bound purified FI and FI from human serum.
- Bound FI retained its serine protease activity, degrading C4b.
- P. intermedia also acquired active C4BP and FH, which supported FI-mediated degradation of C3b and C4b.
Conclusions:
- Prevotella intermedia acquires the complement inhibitor Factor I (FI), retaining its activity.
- The bacterium also acquires active cofactors C4BP and FH, enhancing FI's inhibitory function.
- FI acquisition represents a novel complement evasion strategy for this Gram-negative pathogen linked to chronic diseases.
Related Concept Videos
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Bacterial Meningitis II: Pathophysiology
Mechanism of Conjugation
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Colonisation of Pathogens

